Enoxaparin reduces hepatic vascular resistance and portal pressure in cirrhotic rats

This publication has 41 references indexed in Scilit:

• Efficacy and Safety of Anticoagulation on Patients With Cirrhosis and Portal Vein Thrombosis
  Clinical Gastroenterology and Hepatology, 2012
• Fibrin(ogen)-Independent Role of Plasminogen Activators in Acetaminophen-Induced Liver Injury
  The American Journal of Pathology, 2012
• Protease-activated receptor 2 promotes experimental liver fibrosis in mice and activates human hepatic stellate cells
  Hepatology, 2011
• Heparin Induces Rat Aorta Relaxation via Integrin-Dependent Activation of Muscarinic M ₃ Receptors
  Hypertension, 2010
• Safety and Efficacy of Anticoagulation Therapy With Low Molecular Weight Heparin for Portal Vein Thrombosis in Patients With Liver Cirrhosis
  Journal of Clinical Gastroenterology, 2010
• Sildenafil attenuates pulmonary inflammation and fibrin deposition, mortality and right ventricular hypertrophy in neonatal hyperoxic lung injury
  Respiratory Research, 2009
• Tissue factor-dependent coagulation contributes to α-naphthylisothiocyanate-induced cholestatic liver injury in mice
  American Journal of Physiology-Gastrointestinal and Liver Physiology, 2009
• Factor Xa Stimulates Proinflammatory and Profibrotic Responses in Fibroblasts via Protease-Activated Receptor-2 Activation
  The American Journal of Pathology, 2008
• Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl4 cirrhotic rats
  Journal of Hepatology, 2007
• The Beneficial Effect of Aspirin and Enoxaparin on Fibrosis Progression and Regenerative Activity in a Rat Model of Cirrhosis
  Digestive Diseases and Sciences, 2007